Endurion announces an expansion of its international clinical network, strengthening its ability to deliver scalable, next-generation biologics to patients worldwide.
The expansion connects Endurion’s advanced manufacturing facilities with clinical trial partners and research institutions across Europe, Asia, and North America. By integrating cutting-edge engineering and clinical expertise, this network ensures timely access to innovative therapies, while maintaining rigorous safety and quality standards.
